-
Evaluating the Impact of Subsequent Anticancer Therapy Use on Life-Year and QALY Estimates in Late-Line Metastatic Colorectal Cancer: A Health Economic Analysis of FRESCO-2
Sep 9, 2025, 16:22 PM -
Considerations for Modeling Caregiver Spillover Within Economic Evaluations for Neurological Disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD), and Multiple Sclerosis (MS)
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review and Network Meta-Analysis of Once-Weekly Icosema With Daily Fixed-Dose Combinations of Basal Insulin and GLP-1 RA in Patients With Type 2 Diabetes After 52 Weeks of Treatment
Sep 9, 2025, 16:22 PM -
An Update on the Evolving Use of Artificial intelligence and Machine Learning (AI/ML) in Systematic Literature Reviews (SLRs)
Sep 9, 2025, 16:22 PM -
Medication Patterns of Traditional Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
The Economic Value of Diagnostic Strategies in Hepatitis D: A Methodological Review of Cost-Effectiveness Models
Sep 9, 2025, 16:22 PM -
We Hear What You Are Saying: The Development and Design of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centered Outcomes Research Studies
Sep 9, 2025, 16:22 PM -
Markov Model-Based Cost-Effectiveness Evaluation of ROSA® vs. Manual Total Knee Arthroplasty: Sweden Payer Perspective
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Among Patients Requiring Long-Term Intermittent Catheter Use in England: A Real-World Retrospective Observational Cohort Study
Sep 9, 2025, 16:22 PM -
Health Economic Modeling Approaches for Assessing the Value of a Clostridioides Difficile Vaccination Program: A Literature Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Pediatric and Adult Pneumococcal Conjugate Vaccine Strategies in Canada
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis Of The 13-Valent And 20-Valent Pneumococcal Conjugate Vaccine In The Kazakh Adult Population
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Sep 9, 2025, 16:22 PM -
Negative Symptoms in Schizophrenia: An Observational Study of Patient Characteristics Cost and Healthcare Resource Utilization From a US Healthcare Database
Sep 9, 2025, 16:22 PM -
Leveraging Generative AI for Efficient Patient Safety Narrative Drafting: A Semaglutide Case Study
Sep 9, 2025, 16:22 PM -
A Hierarchical Algorithm to Identify Pregnancy Start and Duration Using Structured EHR Data
Sep 9, 2025, 16:22 PM -
Faricimab vs. Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration: A Cost-Utility Analysis in Italy
Sep 9, 2025, 16:22 PM -
The Broader Economics of Chronic Spontaneous Urticaria (CSU) in Japan: Assessing Societal and Fiscal Benefits of Novel Therapies
Sep 9, 2025, 16:22 PM -
Assessing the Quality of Hemophilia Care: How Suitable Are Patient-Centered Outcomes to Compare Hospital Performance?
Sep 9, 2025, 16:22 PM -
Productivity and Cost-Effectiveness of Initiative for Decentralized Cancer Care in Region Uppsala, Sweden
Sep 9, 2025, 16:22 PM
